NCT06841497View on ClinicalTrials.gov

Safety and Efficacy Assessment of Unani Formulation 'Dolabi' in Management of Diabetes Mellitus Type II

NAActive, not recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

July 4, 2024

Primary Completion Date

July 4, 2025

Study Completion Date

October 3, 2025

Conditions

Diabetes MellitusType 2 DM

Interventions

OTHER

Dolabi

herbal remedy for DM II

Trial Locations (1)

74600

Shifa Ul Mulk Memorial Hospital-Hamdard University, Karachi

All Listed Sponsors

lead

Hamdard University

OTHER